You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

19-039

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Large B-Cell Lymphoma Trial in Beijing, Hangzhou (Prizloncabtagene autoleucel)

Recruiting
  • Relapsed/Refractory Large B-Cell Lymphoma
  • Prizloncabtagene autoleucel
  • Beijing, China
  • +1 more
Mar 24, 2023

B Cell Non-Hodgkin's Lymphoma Trial in Duarte (CD19/CD20-directed CAR-T cells)

Recruiting
  • B Cell Non-Hodgkin's Lymphoma
  • CD19/CD20-directed CAR-T cells
  • Duarte, California
    City of Hope Medical Center
Aug 10, 2022

B Cell Non-Hodgkin's Lymphoma Trial in Beijing (CD19/CD20-directed Chimeric Antigen Receptor T Cells)

Recruiting
  • B Cell Non-Hodgkin's Lymphoma
  • CD19/CD20-directed Chimeric Antigen Receptor T Cells
  • Beijing, China
    Peking University Cancer Hospital
Nov 24, 2021

Non-Hodgkin's B-cell Lymphoma Trial in Hangzhou (CD19/CD20-directed CAR-T cells)

Recruiting
  • Non-Hodgkin's B-cell Lymphoma
  • CD19/CD20-directed CAR-T cells
  • Hangzhou, Zhejiang, China
    First Affiliated Hospital of Zhejiang University College of Medi
Apr 10, 2021

Non-Hodgkin's B-cell Lymphoma Trial in Tianjin (CD19/CD20-directed CAR-T cells)

Recruiting
  • Non-Hodgkin's B-cell Lymphoma
  • CD19/CD20-directed CAR-T cells
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hosipital
Jan 5, 2021

Non-Hodgkin's B-cell Lymphoma Trial in Beijing (CD19/CD20-directed CAR-T cells)

Recruiting
  • Non-Hodgkin's B-cell Lymphoma
  • CD19/CD20-directed CAR-T cells
  • Beijing, Beijing/China, China
    Peking Union Medical College Hospital
Nov 30, 2020

Non-Hodgkin's B-cell Lymphoma Trial in Shanghai (CD19/CD20-directed CAR-T cells)

Unknown status
  • Non-Hodgkin's B-cell Lymphoma
  • CD19/CD20-directed CAR-T cells
  • Shanghai, Shanghai, China
    Shanghai Tongji Hospital, Tongji University School of Medicine
Sep 23, 2020

COVID-19 Trial in Denmark, United States (PF-07304814, Placebo, Remdesivir)

Suspended
  • COVID-19
  • Chula Vista, California
  • +39 more
Mar 22, 2023

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • AZD7442
  • +2 more
  • Tucson, Arizona
  • +123 more
Mar 24, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

Glioma, Solid Tumor Trial in Beijing (GNC-039)

Recruiting
  • Glioma
  • Solid Tumor
  • Beijing, Beijing, China
  • +5 more
Jan 12, 2023

Immunity Against COVID-19 Vaccine in Healthcare Workers in

Active, not recruiting
  • Coronavirus 2019
  • +2 more
  • Immunoglobulin G detection
  • Buenos Aires, Caba, Argentina
    Hospital Italiano de Buenos Aires
Aug 1, 2022

Myocardial Infarction Trial in Assiut (cardiac magnetic resonance)

Active, not recruiting
  • Myocardial Infarction
  • cardiac magnetic resonance
  • Assiut, Egypt
    AssuitU
Jul 18, 2022

Pancreatic Cancer Trial in United States (Atezolizumab, RO7198457, mFOLFIRINOX)

Active, not recruiting
  • Pancreatic Cancer
  • Basking Ridge, New Jersey
  • +6 more
Jan 12, 2022

Tobacco Use and Uptake of COVID-19 Vaccinations

Active, not recruiting
  • COVID-19
  • +3 more
  • Not applicable, this is an observational study
  • Helsinki, Uusimaa, Finland
    Finnish Institute for Health and Welfare
Jul 28, 2022

COVID-19 Trial in Monza (Hematolgy and Chemistry analysis, Real Time PCR, PROS assay COVID+)

Recruiting
  • COVID-19
  • Hematolgy and Chemistry analysis
  • +5 more
  • Monza, Lombardia, Italy
    San Gerardo Hospital
Apr 27, 2022

COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)

Completed
Has Results
  • COVID-19
  • +2 more
  • pathogen reduced SARS-CoV-2 convalescent plasma
  • Placebo
  • Little Rock, Arkansas
  • +25 more
Oct 6, 2022

Assessment of Functional Capacity in Long-COVID

Active, not recruiting
  • Post-COVID-19 Syndrome
  • Long COVID
  • Physiotherapy
  • Rio de Janeiro, Brazil
  • +1 more
Jul 28, 2023

Covid-19 Trial in Lake Success (Famotidine, Placebo)

Active, not recruiting
  • Covid-19
  • Lake Success, New York
    Northwell Health
Apr 4, 2022

COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.

Completed
  • Covid19
  • +2 more
    • Mexico City, Mexico
      Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
    Feb 23, 2022

    Respiratory Syncytial Virus Infections Trial (RSVPreF3 vaccine, Control)

    Not yet recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 vaccine
    • Control
    • (no location specified)
    Jan 20, 2023

    COVID-19 and Brain: Cognition and Mental Health

    Recruiting
    • COVID-19
      • Barcelona, Spain
        University of Barcelona
      Mar 31, 2022

      Pregnancy Complications, Pregnancy, High Risk, Pregnancy Induced Hypertension Trial in Madrid (Exercise program, Healthy

      Recruiting
      • Pregnancy Complications
      • +7 more
      • Exercise program
      • Healthy lifestyle advise
      • Madrid, Spain
      • +1 more
      Jun 28, 2022